| 000 | 01774 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514064116.0 | ||
| 264 | 0 | _c20030714 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 024 | 7 |
_a10.1038/sj.bmt.1703917 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCheng, T | |
| 245 | 0 | 0 |
_aHigh-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cApr 2003 |
||
| 300 |
_a679-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 |
_aBrain Neoplasms _xradiotherapy |
| 650 | 0 | 4 |
_aBusulfan _xadministration & dosage |
| 650 | 0 | 4 |
_aCentral Nervous System Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRadiotherapy _xadverse effects |
| 650 | 0 | 4 | _aStem Cell Transplantation |
| 650 | 0 | 4 |
_aThiotepa _xadministration & dosage |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aForsyth, P | |
| 700 | 1 | _aChaudhry, A | |
| 700 | 1 | _aMorris, D | |
| 700 | 1 | _aGlück, S | |
| 700 | 1 | _aRussell, J A | |
| 700 | 1 | _aStewart, D A | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 31 _gno. 8 _gp. 679-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1703917 _zAvailable from publisher's website |
| 999 |
_c12484502 _d12484502 |
||